5
Citurgia Biochemicals Ltd
CITURGIABIOCHEMICALSLTD NSE
Citurgia Biochemicals Ltd
CommoditiesNSE: CITURGIABIOCHEMICALSLTD BSE: 506373 Chemicals & Petrochemicals
Key Fundamentals
MicrocapCommodity ChemicalsChemicalsMarket Cap
₹1,538 Cr
P/E Ratio
-1,940
EBITDA
₹-0.52 Cr
Return on Equity
6.05%
Debt to Equity
0
Book Value
₹-0.77
52W High
₹212
52W Low
₹47.4
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Citurgia Biochemicals Ltd insights
41 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
Revenue Growth
-
Net Income Growth
85.00% ↗
Cash Flow Change
14.29% ↗
ROE
-16.44% ↘
ROCE
8.43% ↗
EBITDA Margin (Avg.)
-
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.09 | 0.04 | 0.09 | 0.05 | 0.07 | 0.04 | 0.08 | 0.05 | 0.06 | 0.03 | 0.05 | 0.23 | 0.2 |
| Operating Profit | -0.09 | -0.04 | -0.09 | -0.05 | -0.07 | -0.04 | -0.08 | -0.05 | -0.06 | -0.03 | -0.05 | -0.23 | -0.2 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 |
| PBT | -0.15 | -0.09 | -0.15 | -0.11 | -0.13 | -0.09 | -0.14 | -0.11 | -0.12 | -0.08 | -0.11 | -0.29 | -0.26 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.14 | -0.09 | -0.15 | -0.11 | -0.13 | -0.09 | -0.14 | -0.1 | -0.12 | -0.08 | -0.11 | -0.29 | -0.26 |
| EPS in Rs | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.18 | 0.16 | 0.1 | 0.18 | 0.24 | 0.12 | 0.37 | 0.18 | 0.21 | 0.25 | 0.2 | 0.52 |
| Operating Profit | -0.18 | -0.16 | -0.1 | -0.18 | -0.24 | -0.12 | -0.37 | -0.18 | -0.21 | -0.25 | -0.2 | -0.52 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.58 | 0.5 | 0.43 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| PBT | -0.76 | -0.66 | -0.53 | -0.55 | -0.56 | -0.4 | -0.61 | -0.41 | -0.44 | -0.48 | -0.43 | -0.75 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.76 | -0.66 | -0.54 | -0.55 | -0.56 | -0.4 | -0.61 | -0.4 | -0.44 | -0.48 | -0.42 | -0.74 |
| EPS in Rs | -0.06 | -0.05 | -0.04 | -0.04 | -0.04 | -0.03 | -0.05 | -0.03 | -0.03 | -0.04 | -0.03 | -0.06 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 |
| Reserves | -28.35 | -29.01 | -29.55 | -30.1 | -30.66 | -31.06 | -31.67 | -32.08 | -32.51 | -32.99 | -33.41 | -34.15 |
| Borrowings | 4.49 | 4.5 | 5.15 | 6.45 | 6.48 | 6.48 | 6.49 | 6.49 | 6.55 | 6.77 | 6.83 | 6.89 |
| Other Liabilities | 8.59 | 9.67 | 9.93 | 10.05 | 10.13 | 10.13 | 10.36 | 10.6 | 10.73 | 10.84 | 10.92 | 11.31 |
| Total Liabilities | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.6 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
| Fixed Assets | 3.66 | 3.16 | 2.73 | 2.36 | 2.04 | 1.76 | 1.52 | 1.3 | 1.07 | 0.85 | 0.62 | 0.4 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 7.49 | 8.42 | 9.22 | 10.46 | 10.33 | 10.21 | 10.08 | 10.13 | 10.12 | 10.19 | 10.14 | 10.07 |
| Total Assets | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.6 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | -0.13 |
| Investing | 0 | 0 | 0.13 | -0.07 | 0.02 | 0.06 | 0.15 | 0.01 | 0.04 | -0.05 | 0.07 | 0.08 |
| Financing | 0 | 0 | 0.65 | 1.3 | 0.03 | 0 | 0.01 | 0 | 0.06 | 0.22 | 0.06 | 0.06 |
| Net Cash Flow | -0.03 | -0.08 | 0.27 | -0.09 | -0.15 | -0.06 | 0.01 | -0.01 | 0.02 | 0.03 | 0.01 | 0.01 |
| Free Cash Flow | -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | -0.13 |
| CFO/OP | 17 | 50 | 510 | 733 | 79 | 92 | 41 | 17 | 33 | 56 | 60 | 25 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -25.94% | -29.53% | -26.97% | -22.96% | -22.36% | -19.61% | -39.61% | -39.61% | -68.22% | -145.45% | -2150% | — |
Documents
1
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
21 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026 21 Apr - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026
2
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14h - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026 14h - Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31.03.2026
4
Closure of Trading Window
31 Mar - Trading window closed 01-Apr-2026 until two days after Board meeting for audited results for quarter/year ended 31-Mar-2026. 31 Mar - Trading window closed 01-Apr-2026 until two days after Board meeting for audited results for quarter/year ended 31-Mar-2026.
5
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Capacity Addition
17h - Lease for 1,41,392 sq ft in Chennai; ~2,605 desks; ₹35 Crore investment by July 2026. 17h - Lease for 1,41,392 sq ft in Chennai; ~2,605 desks; ₹35 Crore investment by July 2026.
Frequently Asked Questions about Citurgia Biochemicals Ltd
What does Citurgia Biochemicals Ltd do?
Citurgia Biochemicals is engaged in manufactures citric acid, calcium carbonate and plasticizers. Citric acid is traditionally used in foods, soft drinks, confectionary and drugs. It is also used in chemicals, where it provides stable pH conditions for polyester and nylon. Acrylic print curing an...
Where is Citurgia Biochemicals Ltd (506373) listed?
Citurgia Biochemicals Ltd is listed on the Indian stock exchanges. It is listed on NSE: CITURGIABIOCHEMICALSLTD and BSE: 506373. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Citurgia Biochemicals Ltd belong to?
Citurgia Biochemicals Ltd operates in the Commodities sector within the Chemicals & Petrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Citurgia Biochemicals Ltd?
Citurgia Biochemicals Ltd has a market capitalisation of approximately ₹1537.60 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Citurgia Biochemicals Ltd?
The Price-to-Earnings (PE) ratio of Citurgia Biochemicals Ltd is -1940.00. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Citurgia Biochemicals Ltd?
Over the past 52 weeks, Citurgia Biochemicals Ltd has traded between a low of ₹47.4 and a high of ₹212. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Citurgia Biochemicals Ltd?
Citurgia Biochemicals Ltd has a Return on Equity (ROE) of 6.05%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Citurgia Biochemicals Ltd on Tapetide?
On Tapetide, you can view Citurgia Biochemicals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Citurgia Biochemicals is engaged in manufactures citric acid, calcium carbonate and plasticizers. Citric acid is traditionally used in foods, soft drinks, confectionary and drugs. It is also used in chemicals, where it provides stable pH conditions for polyester and nylon. Acrylic print curing and cotton- resist printing.(Source : 201903 Annual Report Page No:62)